Intellectual Property,
Government
May 28, 2019
Bill to ban delays in generic drug access passes the Assembly
A bill just passed by the Assembly takes aim at a pharmaceutical industry practice that some argue delays access to some lower-priced generic drugs. The bill is sponsored by Attorney General Xavier Becerra, whose office would play a major role in enforcing it.
SACRAMENTO — A bill passed by the Assembly takes aim at a pharmaceutical industry practice some argue delays access to some lower-priced generic drugs. The bill is sponsored by Attorney General Xavier Becerra, whose office would play a major role in enforcing it.
AB 824 would bar so-called pay-to-delay schemes in which pharmaceutical companies sign anti-competitive legal settlements with generic drug makers. The bill’s author, Asse...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In